MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-08-2023
Tabula Rasa HealthCare Interest Expense 2011-2026 | TRHC
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Tabula Rasa HealthCare
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.06 M | -9.11 M | -20.7 M | 16 M | 906 K | 688 K | 4.49 M | 5.92 M | 1.35 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16 M | -20.7 M | 61.2 K |
Quarterly Interest Expense Tabula Rasa HealthCare
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 566 K | 452 K | - | 479 K | -2.44 M | -2.27 M | - | -2.23 M | 2.18 M | 2.55 M | - | 4.72 M | 4.67 M | 4.61 M | - | 4.44 M | 4.31 M | 2.69 M | - | 232 K | 120 K | 63 K | - | 174 K | 77 K | 76 K | - | 1.24 M | 1.5 M | 1.5 M | - | 1.47 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.72 M | -2.44 M | 1.3 M |
Interest Expense of other stocks in the Health information services industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
-147 K | - | 0.29 % | $ 206 M |  USA |
 |
Cerner Corporation
CERN
|
43.5 M | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
12.5 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
32 M | - | - | $ 2.94 B | USA |
 |
Change Healthcare
CHNG
|
234 M | - | - | $ 9.03 B | USA |
 |
iCAD
ICAD
|
-49 K | - | - | $ 102 M | USA |
 |
Evolent Health
EVH
|
15.6 M | $ 2.88 | 14.74 % | $ 270 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
13.2 M | - | -10.39 % | $ 886 M | USA |
 |
GoodRx Holdings
GDRX
|
-2.66 M | $ 2.32 | 4.04 % | $ 895 M | USA |
 |
MTBC
MTBC
|
-265 K | - | -0.58 % | $ 51.7 M | USA |
 |
Akerna Corp.
KERN
|
-221 K | - | - | $ 161 M | USA |
 |
NextGen Healthcare
NXGN
|
3.52 M | - | - | $ 1.6 B | USA |
 |
10x Genomics
TXG
|
33 K | $ 25.35 | 2.22 % | $ 2.97 B | USA |
 |
OptimizeRx Corporation
OPRX
|
1.45 M | $ 6.4 | 5.79 % | $ 110 M | USA |
 |
1Life Healthcare
ONEM
|
-13.8 M | - | - | $ 3.37 B | USA |
 |
HealthEquity
HQY
|
12.1 M | $ 83.67 | 2.84 % | $ 7.21 B | USA |
 |
Premier
PINC
|
102 M | - | - | $ 2.33 B | USA |
 |
Schrödinger
SDGR
|
16.4 M | $ 12.4 | 4.11 % | $ 911 M | USA |
 |
Phreesia
PHR
|
2.95 M | $ 9.06 | 5.35 % | $ 541 M | USA |
 |
Teladoc Health
TDOC
|
10.4 M | $ 5.54 | 5.62 % | $ 976 M | USA |
 |
Signify Health
SGFY
|
20.6 M | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
-2 K | - | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
-2.65 M | - | -46.64 % | $ 10.4 M | USA |
 |
SCWorx Corp.
WORX
|
279 K | - | - | $ 7.71 M | USA |
 |
American Well Corporation
AMWL
|
5.17 M | $ 6.24 | 14.39 % | $ 100 M | USA |
 |
HealthStream
HSTM
|
-318 K | $ 21.04 | 3.44 % | $ 639 M | USA |
 |
Omnicell
OMCL
|
-270 K | $ 37.53 | 3.3 % | $ 1.73 B | USA |
 |
Progyny
PGNY
|
1.87 M | $ 17.39 | 1.28 % | $ 1.49 B | USA |
 |
So-Young International
SY
|
12 M | $ 2.74 | -0.72 % | $ 218 M |  China |
 |
Veeva Systems
VEEV
|
278 M | $ 167.3 | 5.16 % | $ 27.4 B | USA |
 |
Zhongchao
ZCMD
|
34 K | $ 2.03 | 2.27 % | $ 6.94 M | China |